Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load

Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489 (2003).

Murphy, M. P. & LeVine, H. III. Alzheimer’s disease and the amyloid-beta peptide. J. Alzheimers. Dis. 19, 311–323 (2010).

Masters, C. L. et al. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 4, 2757–2763 (1985).

Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249 (1985).

Glenner, G. G. & Wong, C. W. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131–1135 (1984).

Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698–712 (2011).

Salloway, S. et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N. Engl. J. Med. 370, 322–333 (2014).

Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease. Nature 518, 365–369 (2015).

Wu, Y., Dissing-Olesen, L., MacVicar, B. A. & Stevens, B. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. 36, 605–613 (2015).

Iaccarino, H. F. et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540, 230–235 (2016).

Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model. Cell 160, 1061–1071 (2015).

Kreutzberg, G. W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312–318 (1996).

Raivich, G. et al. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res. Rev. 30, 77–105 (1999).

Eckhorn, R. et al. Coherent oscillations: a mechanism of feature linking in the visual cortex? Biol. Cybern. 60, 121–130 (1988).

Oakley, H. et al. Intraneuronal NL-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140 (2006).

Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue beta amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159–170 (2004).

Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nature 497, 332–337 (2013).

Murray, E. et al. Simple, scalable proteomic imaging for high-dimensional profiling of intact systems. Cell 163, 1500–1514 (2015).

Cardin, J. A. et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663–667 (2009).

Allen, B. D., Singer, A. C. & Boyden, E. S. Principles of designing interpretable optogenetic behavior experiments. Learn. Mem. 22, 232–238 (2015).

Teng, F. et al. Square or sine: finding a waveform with high success rate of eliciting SSVEP. Comput. Intell. Neurosci. 2011, 1–5 (2011).

Treuting, P. M. & Snyder, J. M. Mouse necropsy. Curr. Protoc. Mouse Biol. 5, 223–233 (2015).

Chung, K. & Deisseroth, K. CLARITY for mapping the nervous system. Nat. Methods 10, 508–513 (2013).

Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat. Protoc. 9, 1682–1697 (2014).

Helwig, M. et al. The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J. Biol. Chem. 288, 1114–1124 (2013).

Ohmi, K., Zhao, H.-Z. & Neufeld, E. F. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS ONE 6, e27461 (2011).

Mastrangelo, M. A. et al. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer’s disease-related pathologies in male triple-transgenic mice. BMC Neurosci. 9, 81 (2008).

Sudol, K. L. et al. Generating differentially targeted amyloid-β specific intrabodies as a passive vaccination strategy for Alzheimer’s disease. Mol. Ther. 17, 2031–2040 (2009).

Garcia, J. A. et al. Isolation and analysis of mouse microglial cells. Curr. Protoc. Immunol. 104, 14.35.1–14.35.15 (2014).

Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337–351 (2007).

Beck, S. J. et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease. Nat. Commun. 7, 11483 (2016).

Brai, E., Alina Raio, N. & Alberi, L. Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease. Acta Neuropathol. Commun. 4, 64 (2016).

Hanisch, U.-K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394 (2007).

Ransohoff, R. M. A polarizing question: do M1 and M2 microglia exist? Nat. Neurosci. 19, 987–991 (2016).

Bessis, A., Béchade, C., Bernard, D. & Roumier, A. Microglial control of neuronal death and synaptic properties. Glia 55, 233–238 (2007).